MiniMed Group, Inc. MMED
Set alert
As of Nov 3, 10:13 AM ET
- YTD
- +2.38%
- 1 year
- +2.38%
- Open
- 18.82
- Prev close
- 18.90
- Mkt cap
- 5.32B
- Vol
- 446.56K
- Avg vol
- 7.30M
- EPS
- -1.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.51
- High
- 18.95
- Forward P/E
- 27.22
- Beta
- 0.00
- Short ratio
- 1.61
- Inst. own
- 21.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 30, 2026
- 50-d avg
- 20.15
- 200-d avg
- 16.60
- 1y target
- 25.47
News
53 minutes ago prnewswire.com
MiniMed Appoints Dr. David Segal as Chief Medical Officer
NORTHRIDGE, Calif., Nov. 3, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the appointment of David Segal, M.D.
4 days ago benzinga.com
Bears Load Up on Ondas, Dutch Bros and 8 More Stocks — Is a Squeeze Brewing?
Ondas, Dutch Bros and Under Armour are among the most-heavily shorted stocks in the market right now.
-
2 weeks ago benzinga.com
MiniMed Names Kevin E. Lofton Board Chair, Effective Separation From Medtronic
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the completion of the company's separation from Medtronic. This new…
2 weeks ago benzinga.com
Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’
Cramer favors McKesson and Medtronic, while avoiding X-Energy and Cipher; he says Vishay is overpriced and advises waiting for a dip.
3 weeks ago benzinga.com
Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse
Dutch Bros, SoundHoundAI, Kohl's and Ondas are among the top ten most-heavily shorted stocks in the market right now.
-
3 weeks ago benzinga.com
Medtronic’s Previously Announced MiniMed Share Exchange Offer Oversubscribed As Company Moves To Exchange Remaining 252,813,348 Shares; 4.5939 Shares Of MiniMed Common Stock Will Be Exchanged For Each Medtronic Ordinary Share Accepted In The Exchange Offer
Medtronic plc ((Medtronic, NYSE:MDT) today announced that, based on preliminary results, its previously announced offer to exchange shares of common stock of MiniMed Group, Inc. ((MiniMed,…
-
3 weeks ago benzinga.com
Jefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22
Jefferies analyst Michael Toomey initiates coverage on Minimed Group (NASDAQ:MMED) with a Hold rating and announces Price Target of $22.
-
3 weeks ago benzinga.com
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28
Mizuho analyst Anthony Petrone maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $26 to $28.
3 weeks ago benzinga.com
Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus
Cramer dislikes Rambus and MiniMed, calls GigaCloud highly speculative, sees Babcock & Wilcox as a small bet, and favors ADM and Deere.
-
3 weeks ago benzinga.com
Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22
Barclays analyst Christopher Pasquale initiates coverage on Minimed Group (NASDAQ:MMED) with a Equal-Weight rating and announces Price Target of $22.
-
4 weeks ago benzinga.com
MiniMed Study Links More Alert Responses To Better Diabetes Control
MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today presented new clinical evidence showing that people with type 1 diabetes using the MiniMed Smart MDI system who responded to more…
1 month ago benzinga.com
Squeeze Watch: 10 Stocks With Over 33% Short Interest
Ten stocks have over 34% of their float short, with ONDS and BROS on the list led by VG.
-
1 month ago benzinga.com
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29
Truist Securities analyst Richard Newitter initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $29.
-
1 month ago benzinga.com
MiniMed Files Form S-4 with SEC For Medtronic Exchange Offer Covering 225M Shares of MiniMed Common Stock
MiniMed (NASDAQ:MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in connection with Medtronic plc's ((", Medtronic", ,
-
2 months ago benzinga.com
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21
Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $19 to $21.
-
2 months ago benzinga.com
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26
Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $23 to $26.
-
2 months ago benzinga.com
Evercore ISI Group Maintains Outperform on Minimed Group, Raises Price Target to $27
Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $20 to $27.
-
2 months ago benzinga.com
Wells Fargo Maintains Overweight on Minimed Group, Raises Price Target to $26
Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $22 to $26.
2 months ago benzinga.com
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other stocks rallied on strong results.
2 months ago benzinga.com
These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28.
-
2 months ago benzinga.com
UBS Maintains Buy on Minimed Group, Raises Price Target to $28
UBS analyst Patrick Wood maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $25 to $28.
-
2 months ago benzinga.com
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $26
Mizuho analyst Anthony Petrone maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $21 to $26.
-
2 months ago benzinga.com
B of A Securities Maintains Buy on Minimed Group, Raises Price Target to $28
B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $24 to $28.
-
2 months ago benzinga.com
BTIG Maintains Buy on Minimed Group, Raises Price Target to $28
BTIG analyst Marie Thibault maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $25 to $28.
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares rose 43.1% to $6.53 during Tuesday's regular session. The company's market cap stands at $2.7 million. USBC (AMEX:USBC) stock moved upwards by…
2 months ago benzinga.com
Minimed Group Q1 2027 Earnings Call Transcript
On Tuesday, Minimed Group (NASDAQ:MMED) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For…
2 months ago benzinga.com
Yext Posts Upbeat Q2 Earnings, Joins Fervo Energy, MiniMed Group And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Nasdaq Composite falling around 1% on Tuesday. Shares of Yext Inc (NYSE:YEXT) rose sharply after the company reported better-than-expected second-quarter earnings.…
-
2 months ago benzinga.com
Minimed Group Q1 Sales $843.000M Beat $827.065M Estimate
Minimed Group (NASDAQ:MMED) reported quarterly sales of $843.000 million which beat the analyst consensus estimate of $827.065 million by 1.93 percent. This is a 16.60 percent increase over sales of…
2 months ago benzinga.com
Top Wall Street Forecasters Revamp MiniMed Group Expectations Ahead Of Q1 Earnings
MiniMed Group, Inc. (MMED) will report Q1 earnings on Sept. 1. Analysts expect 9 cents/share, down from 35 cents/share last year. Stock closed at $19.51.
2 months ago benzinga.com
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.
-
5 months ago benzinga.com
Wells Fargo Maintains Overweight on Minimed Group, Lowers Price Target to $22
Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and lowers the price target from $26 to $22.
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
5 months ago benzinga.com
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday
Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELYB, NN, BVC, MX, ECX, DRTS, RZLT, SYRE, TGTX.
-
5 months ago benzinga.com
Full Transcript: Minimed Group Q4 2026 Earnings Call
Full Transcript: Minimed Group Q4 2026 Earnings Call
-
5 months ago benzinga.com
Minimed Group Q4 EPS $(0.68) Misses $0.11 Estimate, Sales $837.000M Beat $789.096M Estimate
Minimed Group (NASDAQ:MMED) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $0.11 by 718.18 percent. This is unchanged from the same period last year.…
-
5 months ago benzinga.com
MiniMed Announces Expanded Agreement With Abbott To Collaborate On Commercializing Dual Glucose-Ketone Sensors Designed To Integrate Exclusively With MiniMed Smart Dosing Systems
Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes managementNORTHRIDGE, Calif., June 3, 2026 /CNW/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes…
-
5 months ago benzinga.com
B of A Securities Maintains Buy on Minimed Group, Lowers Price Target to $20
B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and lowers the price target from $27 to $20.
-
5 months ago benzinga.com
Benchmark Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $20
Benchmark analyst Bruce Jackson initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $20.
-
6 months ago benzinga.com
MiniMed Group Announces Health Canada License New Software For MiniMed 780G System
MiniMed Group, Inc. ((MiniMed, NASDAQ:MMED), a global leader in insulin delivery, announced Health Canada has licensed new software for the MiniMed™ 780G system, marking a meaningful step forward in…
-
6 months ago benzinga.com
Medtronic Reports Cybersecurity Breach, Says No Impact On Patients Or Operations
On April 24, 2026, Medtronic plc ("Medtronic"), the parent company of MiniMed Group, Inc. ("MiniMed"), announced that an unauthorized third party had accessed data in certain of Medtronic's…
6 months ago benzinga.com
Vicor, AXT And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
US stock futures rise, Vicor Corp shares dip 2.2% in pre-market trading after beating earnings and sales estimates. Other stocks also decline.
6 months ago benzinga.com
Goldman Sachs' 2 Favorite Under-the-Radar Stocks
Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profitable stock, with a target price of $24. MiniMed produces insulin pump platforms and continuous…
7 months ago benzinga.com
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves
MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising competition and past share losses.
7 months ago benzinga.com
This Sensata Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Wall Street analysts changed outlook on top stocks. See ratings changes for MTRN, AQN, SXT, MMED, and TDW. Check out analysts' views on SXT.
-
7 months ago benzinga.com
Barclays Initiates Coverage On Minimed Group with Overweight Rating, Announces Price Target of $26
Barclays analyst Matt Miksic initiates coverage on Minimed Group (NASDAQ:MMED) with a Overweight rating and announces Price Target of $26.
-
7 months ago benzinga.com
William Blair Initiates Coverage On Minimed Group with Outperform Rating
William Blair analyst Steven Lichtman initiates coverage on Minimed Group (NASDAQ:MMED) with a Outperform rating.
-
7 months ago benzinga.com
Citigroup Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $23
Citigroup analyst Joanne Wuensch initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $23.
-
7 months ago benzinga.com
Piper Sandler Initiates Coverage On Minimed Group with Neutral Rating, Announces Price Target of $16
Piper Sandler analyst Matt O'Brien initiates coverage on Minimed Group (NASDAQ:MMED) with a Neutral rating and announces Price Target of $16.
-
7 months ago benzinga.com
Mizuho Initiates Coverage On Minimed Group with Outperform Rating, Announces Price Target of $21
Mizuho analyst Anthony Petrone initiates coverage on Minimed Group (NASDAQ:MMED) with a Outperform rating and announces Price Target of $21.